ZA936192B - Serum free medium. - Google Patents
Serum free medium.Info
- Publication number
- ZA936192B ZA936192B ZA936192A ZA936192A ZA936192B ZA 936192 B ZA936192 B ZA 936192B ZA 936192 A ZA936192 A ZA 936192A ZA 936192 A ZA936192 A ZA 936192A ZA 936192 B ZA936192 B ZA 936192B
- Authority
- ZA
- South Africa
- Prior art keywords
- serum free
- free medium
- medium
- thrombin
- insulin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5412—IL-6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/565—IFN-beta
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/76—Undefined extracts from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/24—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/25—Tumour necrosing factors [TNF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/33—Insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL10292992A IL102929A (en) | 1992-08-24 | 1992-08-24 | Serum-free medium for mammalian cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA936192B true ZA936192B (en) | 1994-03-22 |
Family
ID=11063947
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA936192A ZA936192B (en) | 1992-08-24 | 1993-08-24 | Serum free medium. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5641647A (ja) |
| EP (2) | EP1045023B1 (ja) |
| JP (1) | JP4124493B2 (ja) |
| AT (2) | ATE226632T1 (ja) |
| AU (1) | AU670957B2 (ja) |
| CA (1) | CA2104643C (ja) |
| CY (1) | CY2572B1 (ja) |
| DE (2) | DE69334097T2 (ja) |
| DK (2) | DK1045023T3 (ja) |
| ES (2) | ES2274756T3 (ja) |
| IL (1) | IL102929A (ja) |
| PT (2) | PT584788E (ja) |
| ZA (1) | ZA936192B (ja) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9303601D0 (sv) * | 1993-11-01 | 1993-11-01 | Kabi Pharmacia Ab | Improved cell cultivation method and medium |
| AU4330597A (en) | 1996-08-30 | 1998-03-19 | Life Technologies, Inc. | Serum-free mammalian cell culture medium, and uses thereof |
| US6692961B1 (en) * | 1996-10-11 | 2004-02-17 | Invitrogen Corporation | Defined systems for epithelial cell culture and use thereof |
| WO1998026084A1 (en) * | 1996-12-09 | 1998-06-18 | Wolfgang Andreas Renner | Expression of active interferon beta 1 using recombinant rna replicons |
| SE9700983D0 (sv) * | 1997-03-18 | 1997-03-18 | Ascendia Ab | Stimulering, odling och preservation av pankreas- och andra celler |
| IL143243A0 (en) * | 1998-11-19 | 2002-04-21 | Organogenesis Inc | A cultured tissue construct containing fibroblast cells and methods for the production thereof |
| EP1754784A3 (en) * | 1999-09-03 | 2007-02-28 | Applied Research Systems ARS Holding N.V. | Method for producing a heterologous secreted protein from chinese hamster ovary cells grown on microcarriers |
| UA74557C2 (en) | 1999-09-03 | 2006-01-16 | Applied Research Systems | A method for producing a heterologous secreted protein from chinese hamster ovaries cells grown on microcarriers |
| US7445924B2 (en) | 2000-11-23 | 2008-11-04 | Bavarian Nordic A/S | Modified Vaccinia Ankara virus variant and cultivation method |
| US6506576B2 (en) | 2001-03-14 | 2003-01-14 | Board Of Trustees Of The University Of Arkansas | Serum-and steroid-free culture media for cerebellar granule neurons |
| EA009008B1 (ru) | 2002-09-05 | 2007-10-26 | Бавариан Нордик А/С | Способ амплификации вируса оспы |
| WO2007103447A2 (en) * | 2006-03-06 | 2007-09-13 | Humagene, Inc. | A method for the preparation of recombinant human thrombin |
| US8415094B2 (en) * | 2007-12-21 | 2013-04-09 | Jaffar Ali bin M. Abdullah | Protein-free gamete and embryo handling and culture media products |
| CN103898123B (zh) * | 2012-12-28 | 2019-03-15 | 北京韩美药品有限公司 | 重组人IFN-β-1a及其生产和纯化方法 |
| EP2964749A4 (en) * | 2013-03-08 | 2016-08-17 | Neuclone Biolog Pty Ltd | COMPOSITION OF CELL CULTURE MEDIA AND METHODS OF PRODUCTION THEREOF |
| PL2964768T3 (pl) | 2013-03-08 | 2021-01-11 | Neuclone Biologics Pty Ltd | System ekspresji komórkowej |
| CN103484426B (zh) * | 2013-10-15 | 2014-11-26 | 齐鲁制药有限公司 | 一种无动物源的低蛋白培养基 |
| CN104593318B (zh) * | 2013-10-31 | 2018-05-04 | 中国食品发酵工业研究院 | 一种用于细胞培养基的玉米活性肽添加剂 |
| US9534026B2 (en) | 2013-10-31 | 2017-01-03 | China National Research Institute Of Food & Fermentation Industries | Corn active peptide additive for cell culture medium |
| JP7521738B2 (ja) * | 2020-05-18 | 2024-07-24 | キヤノン株式会社 | 目的細胞の生産方法、目的細胞による生産物の生産方法、および無血清培地 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0449950A4 (en) * | 1988-12-14 | 1991-10-16 | Us Health | Cell culture medium for human liver epithelial cell line |
| ZA901280B (en) * | 1989-02-27 | 1991-10-30 | Lilly Co Eli | Tissue culture method |
| GB9022545D0 (en) * | 1990-10-17 | 1990-11-28 | Wellcome Found | Culture medium |
| US5256766A (en) * | 1991-02-19 | 1993-10-26 | The Regents Of The University Of California | Recombinant thrombin receptor and related pharmaceuticals |
-
1992
- 1992-08-24 IL IL10292992A patent/IL102929A/en not_active IP Right Cessation
-
1993
- 1993-08-23 JP JP20805393A patent/JP4124493B2/ja not_active Expired - Lifetime
- 1993-08-23 CA CA 2104643 patent/CA2104643C/en not_active Expired - Lifetime
- 1993-08-24 DE DE1993634097 patent/DE69334097T2/de not_active Expired - Lifetime
- 1993-08-24 ZA ZA936192A patent/ZA936192B/xx unknown
- 1993-08-24 EP EP20000117026 patent/EP1045023B1/en not_active Expired - Lifetime
- 1993-08-24 EP EP19930113502 patent/EP0584788B1/en not_active Expired - Lifetime
- 1993-08-24 DK DK00117026T patent/DK1045023T3/da active
- 1993-08-24 ES ES00117026T patent/ES2274756T3/es not_active Expired - Lifetime
- 1993-08-24 AU AU44871/93A patent/AU670957B2/en not_active Expired
- 1993-08-24 AT AT93113502T patent/ATE226632T1/de active
- 1993-08-24 AT AT00117026T patent/ATE348147T1/de active
- 1993-08-24 DE DE69332430T patent/DE69332430T2/de not_active Expired - Lifetime
- 1993-08-24 PT PT93113502T patent/PT584788E/pt unknown
- 1993-08-24 US US08/111,428 patent/US5641647A/en not_active Expired - Lifetime
- 1993-08-24 ES ES93113502T patent/ES2185618T3/es not_active Expired - Lifetime
- 1993-08-24 DK DK93113502T patent/DK0584788T3/da active
- 1993-08-24 PT PT00117026T patent/PT1045023E/pt unknown
-
2007
- 2007-02-09 CY CY0700004A patent/CY2572B1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT1045023E (pt) | 2007-02-28 |
| EP0584788B1 (en) | 2002-10-23 |
| ES2185618T3 (es) | 2003-05-01 |
| EP1045023B1 (en) | 2006-12-13 |
| DK0584788T3 (da) | 2003-02-24 |
| PT584788E (pt) | 2003-02-28 |
| ATE226632T1 (de) | 2002-11-15 |
| IL102929A0 (en) | 1993-01-31 |
| EP0584788A3 (en) | 1995-01-18 |
| AU4487193A (en) | 1994-03-03 |
| DK1045023T3 (da) | 2007-03-12 |
| JPH06153931A (ja) | 1994-06-03 |
| DE69332430T2 (de) | 2003-07-17 |
| EP1045023A1 (en) | 2000-10-18 |
| CA2104643C (en) | 2009-07-21 |
| DE69332430D1 (de) | 2002-11-28 |
| JP4124493B2 (ja) | 2008-07-23 |
| EP0584788A2 (en) | 1994-03-02 |
| DE69334097T2 (de) | 2007-07-12 |
| US5641647A (en) | 1997-06-24 |
| AU670957B2 (en) | 1996-08-08 |
| ES2274756T3 (es) | 2007-06-01 |
| DE69334097D1 (de) | 2007-01-25 |
| CY2572B1 (en) | 2008-07-02 |
| CA2104643A1 (en) | 1994-02-25 |
| ATE348147T1 (de) | 2007-01-15 |
| IL102929A (en) | 1996-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2572B1 (en) | Serum free medium | |
| EP0353893A3 (en) | Cell culture bioreactor | |
| AU6619686A (en) | Time duration indicator systems, and also products containing such indicator systems having a limited duration of use or life | |
| AU5330286A (en) | Modified tissue-type plasminogen activator | |
| EP0599651A3 (en) | Bioreactor for the perfusion culture of cells. | |
| AU6110286A (en) | Poly-kringle plasminogen activator | |
| AU1685288A (en) | Cell culture of anchorage dependent cells, materials and products | |
| AU5452986A (en) | Fluidized bioreactor and cell cultivation process | |
| AU7090887A (en) | Plasminogen activators modified in first kringle domain | |
| AU3696784A (en) | Continuous bioreactor and process | |
| EP0297605A3 (en) | Cell culture microcarriers | |
| AU8309387A (en) | Novel plasminogen activators | |
| IE894174L (en) | Process for the preparation of a readily soluble bleach¹activator granulate with a long shelf life | |
| NZ239900A (en) | Serum-free mammalian cell culture medium | |
| EP0259943A3 (en) | Improved shelf and divider arrangement | |
| AU4058589A (en) | Synthetic hiv protease gene and method for its expression | |
| AU1322588A (en) | Carrier storage track for power and free conveyors | |
| AU7037987A (en) | Oxygen generating herbicides synergized with detoxifying enzyme inhibitor | |
| AU2196688A (en) | Modified plasminogen activators | |
| AU7090587A (en) | Modified plasminogen activators | |
| CA2105888A1 (fr) | Utilisation d'un inhibiteur direct de la thrombine pour la fabrication d'un medicament a activite thrombolytique | |
| EP0350887A3 (en) | Serum-free medium and process for cultivating mammalian cells | |
| EP0286688A4 (en) | SUPPORT FOR CELL CULTURE. | |
| EP0201800A3 (en) | A cholesterol-rich fraction, process therefor and use thereof in cell culture | |
| AU1103588A (en) | New plasminogen activators |